in a study of treatment by zidovudine in 106 patients with the acquired immunodeficiency syndrome ( aids ) or aids-related complex , an acute meningo-encephalitic illness developed in 4 of 21 patients within 17 days after the dose of zidovudine had had to be reduced because of myelotoxicity .
C0001175
aids
C0043474
zidovudine